XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.87

-0.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert Goosmann who wrote (3893)	9/24/1997 11:01:00 AM
From: Jinping Shi	of 17367

I am surprised, too. The phase II data was very good and I have no doubt that they will make it statistically significant with 200 samples. It is just a matter of time and opportunity cost while we wait here. Safety data are based on 60 days follow-up, the phase-III trials should not be any longer than that per person. The only thing is how long it takes to enroll 200 patients. It takes at least 4-6 months for FDA to approve it, I guess. It may take 6+ months to write the NDA up. Likely it will be mid-end 1999 to get it approved (my wild guess). They may get it approved in UK and other countries approved first. Anyway, I see more reasons to pay $30 per share now than in 1991. Jinping

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next